Skip to main content
    Q

    Quantum BioPharma Ltd. (QNTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.44
    -0.17 (-10.56%)

    Market Cap: $10.35M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Quantum BioPharma Ltd. (QNTM) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Quantum BioPharma reported EPS of -$0.06. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    38%(5/13)
    Avg Surprise
    -99.62%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A

    Next Report

    No consensus estimate is on file yet for the quarter ending Dec 31, 2026.

    QNTM's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 13 quarters below that had an estimate, QNTM beat 5, missed 7 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2020, when EPS landed 895.24% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.06-$0.70-$0.70 - -$0.70N/AN/AN/A11 up, 0 downNov 12, 2026N/A
    Jun 30, 2026-$0.47-$0.59-$0.59 - -$0.59+20.34%BeatN/A11 up, 0 downAug 13, 2026N/A
    Mar 31, 2026-$4.17-$0.68-$0.68 - -$0.68-513.24%MissN/A11 up, 0 downMay 7, 2026N/A
    Sep 30, 2025-$1.77-$3.70-$3.70 - -$3.70+52.16%BeatN/A10 up, 0 downNov 7, 2025N/A
    Jun 30, 2025-$3.06N/AN/AN/AN/AN/AN/AN/AAug 6, 2025N/A
    Mar 31, 2025-$2.33N/AN/AN/AN/AN/AN/AN/AMay 14, 2025N/A
    Dec 31, 2024-$2.70-$3.25-$3.25 - -$3.25N/AN/AN/A10 up, 0 downMar 28, 2025N/A
    Sep 30, 2024-$4.17-$3.90-$3.90 - -$3.90-6.92%MissN/A10 up, 0 downNov 12, 2024N/A
    Jun 30, 2024-$5.20-$3.90N/A-33.33%MissN/AN/AN/AAug 14, 2024N/A
    Mar 31, 2024-$3.25-$3.25N/A0.00%In lineN/AN/AN/AMay 14, 2024N/A
    Dec 31, 2023-$9.75-$9.09N/A-7.25%MissN/AN/AN/AMar 28, 2024N/A
    Sep 30, 2023-$0.03-$0.14N/A+78.57%BeatN/AN/AN/ANov 15, 2023N/A
    Jun 30, 2023-$0.14N/AN/AN/AN/AN/AN/AN/AJul 20, 2023N/A
    Mar 31, 2023-$16.61N/AN/AN/AN/AN/AN/AN/AMay 12, 2023N/A
    Dec 31, 2022Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 31, 2023N/A
    Sep 30, 2022-$12.13N/AN/AN/AN/AN/AN/AN/ANov 11, 2022N/A
    Jun 30, 2022-$7.47N/AN/AN/AN/AN/AN/AN/AAug 12, 2022N/A
    Mar 31, 2022-$9.60N/AN/AN/AN/AN/AN/AN/AApr 1, 2022N/A
    Dec 31, 2021-$10.55-$68.25N/A+84.54%BeatN/AN/AN/AMar 30, 2022N/A
    Sep 30, 2021-$0.15N/AN/AN/AN/AN/AN/AN/ANov 15, 2021N/A
    Jun 30, 2021-$0.35N/AN/AN/AN/AN/AN/AN/AAug 12, 2021N/A
    Mar 31, 2021-$24.02N/AN/AN/AN/AN/AN/AN/AMay 20, 2021N/A
    Dec 31, 2020-$10.55-$1.06N/A-895.24%MissN/AN/AN/AMar 17, 2021N/A
    Sep 30, 2020-$84.50-$46.48N/A-81.80%MissN/AN/AN/ANov 12, 2020N/A
    Jun 30, 2020-$0.50-$72.15N/A+99.30%BeatN/AN/AN/AAug 7, 2020N/A
    Mar 31, 2020-$73.79N/AN/AN/AN/AN/AN/AN/AMay 15, 2020N/A
    Dec 31, 2019-$177.45-$92.30N/A-92.25%MissN/AN/AN/AMar 2, 2020$159195
    Sep 30, 2019-$108.35N/AN/AN/AN/A-472.0%N/AN/ANov 29, 2019$9671
    Jun 30, 2019-$98.74N/AN/AN/AN/A-358.6%N/AN/AAug 28, 2019N/A
    Mar 31, 2019-$16.28N/AN/AN/AN/AN/AN/AN/AMar 31, 2019N/A
    Dec 31, 2018-$150.29N/AN/AN/AN/AN/AN/AN/ADec 31, 2018N/A
    Sep 30, 2018$29.12N/AN/AN/AN/AN/AN/AN/ASep 30, 2018$10706
    Jun 30, 2018$38.18N/AN/AN/AN/AN/AN/AN/AJun 30, 2018$22332
    Last 33 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2024 was -$15.32, after -$26.53 the year before. It was -$82.99 for the year ended Dec 31, 2018, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2024-$15.32N/A
    Dec 31, 2023-$26.53N/A
    Dec 31, 2022-$29.20N/A
    Dec 31, 2021-$35.07N/A
    Dec 31, 2020-$169.34N/A
    Dec 31, 2019-$400.81N/A
    Dec 31, 2018-$82.99N/A

    Frequently Asked Questions About QNTM

    How often does QNTM beat earnings estimates?

    Quantum BioPharma beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of -51.21%.